Juniper

The Bioindustrial Fund

[Michael Luciani @mbluciani]

Three of our portfolio companies just closed their rounds all within a week of each other—cheers to @AltaResTech @Izote_bio @trilobio for making us look good! 🚀

[Michael Luciani @mbluciani]

Juniper hosted a deep-tech GP/LP panel at SF Climate Week. TL;DR: Climate tech isn't dead—it's rebranding. The green premium is gone, but the best companies never needed it anyway.

Thank you to @CendanaCapital, @AsteraInstitute, Dolby Family Ventures, and @Cisco Foundation for sharing!

[Michael Luciani @mbluciani]

There are 37.2T cells in your body, each with 100K chemical reactions every second. Just reading this, your brain’s signals have traveled enough to lap Earth millions of times and since the beginning of this tweet, your body built over 250M new cells. The future of industry won’t be built – it’ll be grown.

[Juniper @juniper_vc]

At $10.6M, Juniper Fund I is officially oversubscribed 🚀 Read more about why Juniper's investments today will be the bioindustrial giants of tomorrow in @TechCrunch https://t.co/faQBFQTv30

[Juniper @juniper_vc]

@jrkelly As a climate biotech incubator for early stage companies, we'd love our founders to be able to access something like this! Would be great to chat.

[Juniper @juniper_vc]

Hi world, we’re Juniper: the Climate Biotech fund. Formerly known as Climate Capital Bio, we’re focused on investing in breakthrough science ready to be commercialized to solve the world’s toughest sustainability problems. Learn what makes us tick: https://t.co/3d2cqapzsX